Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,490.99
(
-0.04%
)
News Focus
News Focus

Replies to post #103997 on Biotech Values

Replies to #103997 on Biotech Values
icon url

DewDiligence

09/12/10 6:04 PM

#104000 RE: Shengli #103997

I bet [MRK] beat this number easily…

MRK can’t possibly report a Boceprevir SVR rate in null responders that beats Telaprevir’s 31% rate in the REALIZE study because MRK’s RESPOND-2 study explicitly excluded null responders.